Abstract:SOCS2, a member of suppressor of cytokine signaling (SOCS) family, is a negative regulator of the signal pathway Janus kinase/signal transducers and activators of transcription (JAK/STAT). Growth hormone (GH) could stimulate lipolysis in adipose tissue. To demonstrate the specific influence of SOCS2 on porcine adipocytes differentiation and lipid metabolism induced by GH, we induced porcine primary adipocytes with 500 ng/ml GH and then tested the triglyceride (TG) accumulation and mRNA expressions of crucial genes in lipid metabolism like peroxisome proliferator-activated receptor gamma (PPARγ), fatty acid synthase (FAS), adipose triglyceride lipase (ATGL), hormone-sensitive lipase (HSL), SOCS2 and SOCS3. Then we retested these genes expressions in different time point after further treatment that over expressed SOCS2 in primary adipocytes and treated with 500 ng/ml GH. Results showed 500 ng/ml GH significantly restrained the porcine primary adipocytes differentiation. Specifically, 0.5 h after the induction with GH, accumulation of TG began to increase, and turned down since 8 h after. GH could promote PPARγ and FAS expressions during earlier stage (0–1 h), restrain from 4 h. However, ATGL and HSL mRNA expressions were stabile increasing. The expression of SOCS2 increased steadily after GH stimulation while SOCS3 expression was instantaneous rise. Overexpression of SOCS2 significantly decreased GH-induced the increase of PPARγ, FAS, ATGL and HSL mRNA expressions in earlier stage (0–1 h), as well as FAS and ATGL protein expression. Otherwise SOCS2 overexpression significantly decreased signal transducers and activators of transcription 3 (STAT3), signal transducers and activators of transcription 5 (STAT5) mRNA expressions and tyrosine phosphorylation levels with GH stimulation. At the same time SOCS3 mRNA kept in a lower level in Ad-SOCS2 transfected adipocytes. In conclusion, SOCS2 might be an important negative regulator of GH signaling in porcine adipocytes, which would provide the ground work for the mechanism of SOCS2 regulation fat metabolism.

SOCS3 Promotes Inflammation and Apoptosis Via Inhibiting JAK2/STAT3 Signaling Pathway in 3T3-L1 Adipocyte.

Silencing SOCS3 Could Inhibit TNF-α Induced Apoptosis in 3T3-L1 and Mouse Preadipocytes

Reactive oxygen species up-regulates SOCS-3 in 3T3-L1 adipocytes

Regulation of Insulin and Leptin Signaling by Muscle Suppressor of Cytokine Signaling 3 (SOCS3)

Silencing SOCS3 expression's inhibitition on TNF-α induced apoptosis in 3T3-L1 preadipocytes

SOCS2 Inhibits Mitochondrial Fatty Acid Oxidation Via Suppressing LepR/JAK2/AMPK Signaling Pathway in Mouse Adipocytes

Relationship Between Suppressor of Cytokine Signaling -3 and Cell Migration and Invasion

Hydrodynamic tail vein injection of SOCS3 eukaryotic expression vector in vivo promoted liver lipid metabolism and hepatocyte apoptosis in mouse.

Hypoxia-inducible Factor 1α Regulates a SOCS3-STAT3-Adiponectin Signal Transduction Pathway in Adipocytes

Effect of Suppressor of Cytokine Signaling 2 (socs2) on Fat Metabolism Induced by Growth Hormone (gh) in Porcine Primary Adipocyte

SOCS3 Was Induced by Hypoxia and Suppressed STAT3 Phosphorylation in Pulmonary Arterial Smooth Muscle Cells.

Suppressor of Cytokine Signaling 3 Inhibits LPS-induced IL-6 Expression in Osteoblasts by Suppressing CCAAT/Enhancer-binding Protein Β Activity

Construction of mice SOCS3 eukaryotic vector and its effects on 3T3-L1 cells apoptosis

SOCS2 Suppresses Inflammation and Apoptosis during NASH Progression through Limiting NF-κB Activation in Macrophages

Retraction Note: SOCS3 Inhibits Insulin Signaling in Porcine Primary Adipocytes.

Restoration of SOCS3 Suppresses Human Lung Adenocarcinoma Cell Growth by Downregulating Activation of Erk1/2, Akt Apart from STAT3

SOCS-1 Inhibits TNF-α-Induced Cardiomyocyte Apoptosis Via ERK1/2 Pathway Activation

Dissociating STAT4 and STAT5 Signaling Inhibitory Functions of SOCS3: Effects on CD8 T Cell Responses

Suppressor of Cytokine Signaling and Insulin Resistance, Leptin Resistance

Suppressor of cytokine signaling 1 inhibits IL-10-mediated immune responses.

SOCS 3 and PPAR-gamma ligands inhibit the expression of IL-6 and TGF-beta1 by regulating JAK2/STAT3 signaling in pancreas